查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496005

全球果冻市场：2024-2029 年预测

Global Biosurgery Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 124 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2022年果冻市场价值为121.14亿美元，复合年增长率为6.70%，到2029年市场规模将达到190.77亿美元。

果冻市场由用于最大限度地减少或减少术中和术后併发症的特定产品组成。果冻产品使手术和其他医疗程序更加高效且复杂。根据产品类型，果冻市场分为特定类型，如止血剂、抗沾黏剂、手术密封剂和骨移植替代品。

手术病例数量的增加和老年人口的增加为果冻产品的市场成长提供了潜力。 65岁以上人口和老年族群广泛利用果冻产品的帮助和帮助。果冻产品在老年族群的医疗和外科手术中的广泛应用正在增加全球市场对果冻产品的需求。此外，慢性病和运动手术导致的手术和外科手术病例数量的增加也推动了果冻市场的成长。

领先公司对果冻产品研发部门的投资增加也导致了这些产品的重大发展和进步。政府对果冻产品新的先进研究和开发的支持也推动了果冻产品市场的发展。医疗领域技术的发展和适应正在扩大果冻市场。

市场驱动因素：

  • 不断增加的研发计划正在推动市场成长。

各大公司加大对果冻产品研发领域的投入，正在推动果冻市场的成长。技术和电子在果冻领域的渗透正在一定程度上推动果冻市场的成长。Medtronic公司开发的先进输注骨移植技术被认为是骨移植植入和果冻产品领域的新发展之一。

美国对新开发的骨移植果冻的核准也显示了该机构对食品药物管理局产品开发的大力支持。 Kuros Biosurgery开发的合成水凝胶技术也是果冻市场的主要开拓之一。

果冻产品研发领域的快速成长正在推动果冻市场的成长。电子和新技术在医疗领域的日益渗透也带来了果冻市场的新进展和开拓。主要公司在果冻产品研发领域的竞争日益激烈，推动了果冻产品在全球市场的快速成长。

  • 手术数量和慢性疾病患者的增加预计将急剧增加对果冻的需求。

手术数量的增加和慢性疾病患者数量的增加是推动果冻市场成长的主要因素。果冻产品提供的便利性和有效性正在导致果冻产品市场的成长。慢性病的增加也促进了果冻市场的成长。

心血管疾病（CVD）病例数量的增加以及果冻产品在心血管疾病手术和治疗中的引入为果冻市场的成长提供了潜力。 CVD手术和移植是医疗领域广泛应用果冻产品的主要领域。老年人口比例的增加也是果冻市场成长的主要驱动力之一。

据美国报告称，全球约有9.62亿人年龄在60岁以上。此外，据报道，60 岁及以上人口的人口成长率为每年 3%。老年人口的增加以及与文明病和慢性病的增加正在推动果冻市场的成长。

北美地区预计将引领市场。

从地理位置来看，北美地区预计将引领果冻市场。慢性病、文明病和肥胖问题的增加正在推动该地区果冻市场的成长。大公司的存在以及对果冻产品研发的投资也推动了北美地区果冻产品市场的发展。

北美以其先进的医疗基础设施、技术进步、高昂的医疗成本、有利的法规环境、慢性病患病率不断上升、主要市场参与者的强大影响力、临床研究和学术合作以及先进的外科技术而闻名。

美国和加拿大拥有最先进的医疗设施、研究机构和医疗保健专业人员网络，为果冻市场的成长提供了有利的环境。该地区高昂的医疗成本、严格的 FDA 标准以及日益普及的慢性病都需要先进的外科干预措施，从而推动了北美对果冻解决方案的需求。该地区已准备好接受这些进步，因此处于果冻市场的前沿。

主要进展：

  • 2022 年 3 月 - Molecular Matrix, Inc. (MMI) 推出 Osteo-P(R)，这是一种用于肌肉骨骼系统的合成骨移植物 (BGS)。该技术采用 MMI 的超交联碳水化合物聚合物 (HCCP) 平台，旨在优化骨骼修復和再生。 Osteo-P(R) BGS 有颗粒状、立方体和条状形式，是从传统材料（如磷酸钙和生物活性玻璃）骨移植物演变而来的。
  • 2022年2月 -GUNZE株式会社获得日本首个吸收性防粘连材料“Tenaleaf（TM）”的製造和销售核准。该产品是GUNZE利用其独特的吸收材料技术开发的，旨在减少开放性手术和微创手术期间的术后器官粘连并改善患者的预后。该产品易于操作，具有适中的黏合强度，可以重新定位，使其成为不断发展的腹腔镜手术领域外科医生的创新解决方案。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章全球果冻市场：依产品类型

  • 介绍
  • 防沾黏剂
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 止血剂
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 手术密封剂
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 骨移植替代品
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 软组织附着
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第六章全球果冻市场：依应用分类

  • 介绍
  • 心臟血管/胸腔外科
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 神经脊椎手术
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 整形外科
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 一般外科
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 其他的
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第七章 全球果冻市场：依来源分类

  • 介绍
  • 天然/生物来源製品
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 合成产品
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第八章全球果冻市场：按地区

  • 介绍
  • 北美洲
    • 依产品类型
    • 按用途
    • 按产地
    • 按国家/地区
  • 南美洲
    • 依产品类型
    • 按用途
    • 按产地
    • 按国家/地区
  • 欧洲
    • 依产品类型
    • 按用途
    • 按产地
    • 按国家/地区
  • 中东/非洲
    • 依产品类型
    • 按用途
    • 按产地
    • 按国家/地区
  • 亚太地区
    • 依产品类型
    • 按用途
    • 按产地
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Baxter International Inc.
  • Johnson &Johnson
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • CryoLife, Inc.
  • Atrium Medical
  • Haemostasis LLC
  • Sanofi
  • Medtronic PLC
  • Kuros Bioscience
简介目录
Product Code: KSI061611887

The global biosurgery market is evaluated at US$12.114 billion for the year 2022, increasing at a CAGR of 6.70% to reach the market size of US$19.077 billion by the year 2029.

The global biosurgery market comprises certain products used to minimize or reduce intra- and post-surgery complications. Biosurgery products offer more efficiency and less complexity in surgery and other medical procedures. Depending on the types of products, the biosurgery market is segmented into certain types, such as hemostatic, anti-adhesive agents, surgical sealing agents, and bone graft substitutes.

The rising number of surgery cases and increasing geriatric population is giving potential to the market growth of global biosurgery products. The population aged 65 and above or the geriatric population is widely using the help and assistance of biosurgery products. The wide application of biosurgery products in medical and surgical procedures in the geriatric population raises the demand for biosurgery products in the global market. The rising cases of surgery and operation procedures due to chronic diseases and sports surgeries are also driving the global biosurgery market growth.

The higher investments by major companies in the research and development section of biosurgery products also result in major developments and advancements in these products. The government's support of new advanced research and developments in biosurgery products is also boosting the global biosurgery products market. The growth and adaptation of technology in the medical field increase the global biosurgery market.

Market Drivers:

  • Increasing research and development programs would bolster market growth.

The higher investments by major players or companies in the research and development sector of biosurgery products are boosting the global biosurgery market growth. The penetration of technology or electronics in the field of biosurgery has boosted the global biosurgery market growth to a certain extent. The development of advanced infused bone graft implantation developed by Medtronic PLC can be considered one of the rising developments in the field of bone graft implantation or biosurgery products.

The approval of the FDA (U.S Food and Drug Administration) for the newly developed bone graft implantation also shows the immense support of governmental agencies in the development of biosurgery products. The synthetic hydrogel technology developed by Kuros Biosurgery can also be counted as one of the major developments in the global biosurgery market.

The rapid growth in the research and development sector of biosurgery products is fuelling the global biosurgery market growth. The increased penetration of electronics and new technology in the medical field also resulted in new advancements and developments in the global biosurgery market. The higher competition of major players in the research and development sector of biosurgery products contributes to the rapid growth of biosurgery products in the global market.

  • A rising number of surgeries & cases of chronic diseases is anticipated to surge the biosurgery demand.

The rising number of surgeries and the increasing number of people with chronic diseases is one of the major factors driving the global biosurgery market growth. The convenience and effectiveness offered by biosurgery products result in the market growth of biosurgery products. The increasing cases of chronic diseases are contributing to the global biosurgery market growth.

The rising cases of cardiovascular diseases (CVDs) and the implementation of biosurgery products in surgeries and treatment of CVDs are giving potential to the global biosurgery market growth. The surgeries and implantations in CVDs are the major sections that widely employ the application of biosurgery products in the medical field. The rising percentage of the geriatric population is also one of the major driving factors in the global biosurgery market growth.

The report of the United Nations states that approximately 962 million people are aged 60 or above in the world. The population growth rate of people above 60 is also reported to be 3% annually. The rise in the geriatric population and increasing cases of lifestyle and chronic diseases are fuelling the global biosurgery market growth.

North America region is expected to lead the market.

Geographically, the North American region is expected to lead the global biosurgery market in the forecasted years. The rising cases of chronic and lifestyle diseases and obesity problems are driving the biosurgery market growth in this region. The presence of major players and the investment in research & development of biosurgery products are also hiking the market of biosurgery products in the North American region.

North America is expected to lead the global biosurgery market due to its advanced healthcare infrastructure, technological advancements, high healthcare expenditure, favorable regulatory environment, increasing prevalence of chronic diseases, strong presence of key market players, clinical research and academic collaboration, and early adoption of advanced surgical techniques.

The United States and Canada have state-of-the-art medical facilities, research institutions, and a network of healthcare professionals, providing a conducive environment for the biosurgery market growth. The region's high healthcare expenditure levels, stringent FDA standards, and increasing prevalence of chronic diseases necessitate advanced surgical interventions, thereby boosting the demand for biosurgery solutions in North America. The region's readiness to embrace these advancements positions it at the forefront of the global biosurgery market.

Key Developments:

  • March 2022- Molecular Matrix, Inc. (MMI) launched its Osteo-P(R) Synthetic Bone Graft Substitute (BGS) for use in the musculoskeletal system. The technology uses MMI's hyper-crosslinked carbohydrate polymer (HCCP) platform, designed to optimize bone repair and regeneration. Osteo-P(R) BGS available in granule, cube, and strip configurations and represents an evolution in bone grafting from traditional materials like calcium phosphate and bioactive glass. Its natural matrix doesn't require a collagen xenograft for better handling and offers real-time healing visualization through radiographic observation of calcium phosphate deposition.
  • February 2022- Gunze Limited obtained medical device approval to manufacture and sell TENALEAF(TM), the first sheet-type absorbable adhesion barrier made in Japan. The product, developed by Gunze using proprietary absorbable material technology, aims to reduce postoperative organ adhesions and improve patient outcomes during open and minimally invasive surgeries. The device allows easy manipulation, moderate adhesive strength for repositioning, and conformable placement, making it an innovative solution for surgeons in the growing field of laparoscopic surgery.

Segmentation:

By Product Type

  • Anti-adhesive agents
  • Hemostatic agents
  • Surgical sealing agents
  • Bone graft substitutes
  • Soft Tissue Attachments

By Application

  • Cardiovascular and Thoracic Surgery
  • Neuro-Spine surgery
  • Orthopedic Surgery
  • General Surgery
  • Others

By Source

  • Natural/Biological Products
  • Synthetic Products

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL BIOSURGERY MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Anti-adhesive agents
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Hemostatic agents
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Surgical sealing agents
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Bone graft substitutes
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Soft Tissue Attachments
    • 5.6.1. Market Opportunities and Trends
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness

6. GLOBAL BIOSURGERY MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Cardiovascular and Thoracic Surgery
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Neuro-Spine surgery
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Orthopedic Surgery
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. General Surgery
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness
  • 6.6. Others
    • 6.6.1. Market Opportunities and Trends
    • 6.6.2. Growth Prospects
    • 6.6.3. Geographic Lucrativeness

7. GLOBAL BIOSURGERY MARKET BY SOURCE

  • 7.1. Introduction
  • 7.2. Natural/Biological Products
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Synthetic Products
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. GLOBAL BIOSURGERY MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By Source
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Application
    • 8.3.3. By Source
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Application
    • 8.4.3. By Source
    • 8.4.4. By Country
      • 8.4.4.1. Germany
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. France
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. UK
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Others
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Application
    • 8.5.3. By Source
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Application
    • 8.6.3. By Source
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. India
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. Japan
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Taiwan
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Indonesia
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects
      • 8.6.4.8. Others
        • 8.6.4.8.1. Market Opportunities and Trends
        • 8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Baxter International Inc.
  • 10.2. Johnson &Johnson
  • 10.3. Becton, Dickinson and Company
  • 10.4. B. Braun Melsungen AG
  • 10.5. CryoLife, Inc.
  • 10.6. Atrium Medical
  • 10.7. Haemostasis LLC
  • 10.8. Sanofi
  • 10.9. Medtronic PLC
  • 10.10. Kuros Bioscience